Just a moment, the page is loading...
Browse ALL STUDIES
Keyword Search
View All Selected
Clear All
Login / Create Account
Login
Create Account
Home
About Us
Privacy Policy
Minimum System Requirements
How To Join
Mission
Data Sponsors
Researchers
How It Works
How to Request Data
Review of Requests
Data Sharing Agreement
Access to Data
Independent Review Panel
Metrics
FAQs
News
Help/Contact Us
Modelling seizure rates rather than time to an event within clinical trials of antiepileptic drugs
Proposal
5906
Title of Proposed Research
Modelling seizure rates rather than time to an event within clinical trials of antiepileptic drugs
Lead Researcher
Laura Bonnett
Affiliation
University of Liverpool
Funding Source
Potential Conflicts of Interest
Data Sharing Agreement Date
26 November 2019
Lay Summary
Within epilepsy research prediction models tend to consider outcomes such as 12 months without seizures, or treatment failure. The underlying statistical model is relatively simple to produce, is familiar to clinicians and is particularly useful to answer short-term questions such as what treatment should be prescribed following diagnosis. However, this statistical modelling approach only considers time to a first event rather than considering all seizures after starting treatment for example. This makes assessing changes in seizure rate over time difficult. Alternative statistical models exists which enable repeated medical events, such as seizures, to be modelled. These have the potential to make more efficient use of the collected seizure data. Ultimately, it is thought that these alternative statistical models will facilitate more accurate estimates of changes in seizure rates over time. This in turn will help to improve the effectiveness of future clinical studies for people with multiple seizures. This study aims to demonstrate the differences between the standard and alternative statistical approaches, and to consider the benefits of the alternative approaches for assessing change in seizure rates over time.
Study Data Provided
[{ "PostingID": 2371, "Title": "UCB-N01061", "Description": "Monotherapy With Levetiracetam in Newly Diagnosed Patients Suffering From Epilepsy" },{ "PostingID": 4828, "Title": "UCB-SP0993", "Description": "A Multicenter, Double-blind, Double-dummy, Randomized, Positive- Controlled Study Comparing the Efficacy and Safety of Lacosamide (200 to 600 mg/Day) to Controlled Release Carbamazepine (400 to 1200 mg/Day), Used as Monotherapy in Subjects (≥ 16 Years) Newly or Recently Diagnosed With Epilepsy and Experiencing Partial-onset or Generalized Tonic-clonic Seizures" }]
Statistical Analysis Plan
Publication Citation
© 2024 ideaPoint. All Rights Reserved.
Powered by ideaPoint.
Help
Privacy Policy
Cookie Policy
Help and Resources